Back to search

Article

Transfusions of Blood Products Derived from Genetic Vaccine Recipients: Safety Concerns and Proposals for Specific Measures

2024-05-29

Abstract excerpt

The World Health Organization declared the coronavirus disease 2019 (COVID-19) pandemic in 2020, following which a global genetic vaccination program has been rapidly implemented as a fundamental solution. However, it has been reported worldwide that the modified mRNAs encoding spike proteins and lipid nanoparticles, which are used as drug delivery systems, not only cause thrombosis and cardiovascular disorders po...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ca366b38-6ee1-55bb-82f2-bc7a7ef35e7e
DOI
10.20944/preprints202403.0881.v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Transfusions of Blood Products Derived from Genetic Vaccine Recipients: Safety Concerns and Proposals for Specific MeasuresDOI 10.20944/preprints202403.0881.v2
Select a neighboring publication to make it the new centre.